REGISTER TODAY!

SHIVER - 1st International Workshop in Steatohepatitis in HIV - April 26, 2019

Start Date:4/26/2019

Start Time:9:00 AM EDT

Duration:420 minutes

Abstract:

Presented live from Montreal, Canada

If you're already registered for the SHIVER - 1st International Workshop in Steatohepatitis in HIV - April 26, 2019 webcast, click below:

ALREADY REGISTERED?

Speakers

Dr Giada Sebastiani

Giada Sebastiani is Associate Professor of Medicine at McGill University and Clinician Scientist at the Research Institute of McGill University Health Centre in Montreal, Canada. She provides clinical services in the Division of Gastroenterology and Hepatology. She received a medical degree and specialized in internal medicine at the University of Padua, Italy. She had training in clinical and basic research at Harvard Medical School (US), University College of London (UK), University of Bordeaux (France) and Lady Davis Institute for Medical Research (Montreal, Canada). Her work focuses on fatty liver disease, liver fibrosis and non-invasive diagnostic tools in liver disease, with a current focus on people living withb HIV. She is author of 70 articles in peer-reviewed journals (including Hepatology, Journal of Hepatology, Clinical Infectious Diseases, AIDS), 15 book chapters, 130 conference publications at national and international congresses. She has been invited speaker in 60 international congresses and universities, including European, Asian Pacific, Mexican, Italian and Canadian Associations for the Study of the Liver. She was awarded the Clinical Research Salary Award from Fonds Recherche Sante Quebec. Other honors include: honorary membership of the Romanian Association for the Study of the Liver; Emerging Stars in Hepatology Award (Asian Pacific Association for the Study of the Liver, 2010); Top 10 cited papers 2006-2008 Award by Journal of Hepatology - European Association for the Study of the Liver.

Mr. Kenneth Monteith

Ken Monteith est directeur général de la COCQ-SIDA (la Coalition des organismes communautaires québécois de lutte contre le sida). Formé en droit, il a travaillé dans le secteur communautaire jeunesse et le secteur VIH/sida. Il participe activement à la recherche, surtout sur les projets concernant la qualité de vie des personnes vivant avec le VIH et la prévention auprès des hommes ayant des relations sexuelles avec des hommes. Il détient des diplômes en relations industrielles, droit civil et droit commun de l'Université McGill et était membre du Barreau du Québec de 1991 au 2001, quand il a démissionné pour dévouer toute son énergie à son travail de lutte contre le VIH-sida. Ken Monteith a été diagnostiqué avec une infection au VIH en stade avancé en 1997. ________________________________________ Ken Monteith is the Executive Director of COCQ-SIDA (la Coalition des organismes communautaires québécois de lutte contre le sida). Trained as a lawyer, he worked in the community youth sector and in the HIV/AIDS sector. He participates actively in research, especially projects concerning the quality of life of people living with HIV and prevention for men who have sex with men. He holds degrees in Industrial Relations, Common and Civil Law from McGill University and was a member of the Québec Bar from 1991 to 2001, when he resigned to devote himself more fully to his community work on HIV/AIDS. Ken Monteith was diagnosed with advanced HIV infection in 1997.

Dr. Emmanuel Tsochatzis

Dr Emmanuel Tsochatzis (MD, MSc, FEBTM, FRCP, PhD) finished his training and PhD in Hippokration General Hospital in Greece, before moving to the Royal Free Hospital for his post-doc research under Professor Andy Burroughs. Since 2014, he is an Associate Professor and Consultant Hepatologist at the UCL Institute for Liver and Digestive Health, Royal Free Hospital in London. His main research interests include non-alcoholic fatty liver disease, cirrhosis and portal hypertension and non-invasive assessment of liver fibrosis. He is the recipient of the Rising Star in Gastroenterology prize by the UEG and the EASL Physician Scientist Fellowship. He is a member of the steering committee of the Baveno collaboration on portal hypertension. His work on the cost-effectiveness of non-invasive fibrosis tests has informed the World Health Organization (WHO) guidelines on diagnosis and treatment of both HBV and HCV. He has published more than 180 articles in peer-reviewed journals and has an h-index of 43.

Dr. Caryn Morse

Dr. Morse is an infectious diseases specialist with an interest in non-alcoholic fatty liver disease and other metabolic disorders in HIV-infected patients. She received her medical degree from the University of Virginia and completed residency training in internal medicine and fellowship training in infectious diseases at Wake Forest University/Baptist Medical Center. Following fellowship, she completed additional clinical research training at the NIH Clinical Center/NIAID HIV Research Clinic and remained on staff at the Clinical Center as a Clinical Investigator until 2017. In 2017, she joined the faculty of Wake Forest University as an Associate Professor of Infectious Diseases.

Dr Lisa Barrett

Dr. Lisa Barrett is an assistant professor in the Department of Microbiology & Immunology as well as the Department of Medicine in the Faculty of Medicine at Dalhousie University. She earned a bachelor’s degree, a medical degree, and a PhD at the Memorial University of Newfoundland. She has completed fellowships at Dalhousie University, the University of Toronto, and the National Institute of Allergy and Infectious Diseases. Some of Dr. Barrett’s research interests include HCV treatment for vulnerable populations, the role of chronic viral infection in chronologic and immunologic aging and the modulation of the immune response to generate therapeutic and prophylactic vaccines in persistent viral infections. She was a contributing author to the 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment.

Dr. Giovanni Guaraldi

Dr Giovanni Guaraldi is Assistant Professor of Infectious disease at University of Modena and Reggio Emilia (Italy). He is Director of the Modena University Centre for Cooperation and Development and he is the coordinator of the European ACP project CoBaSys (Community Based System in HIV Treatment) focused on antiretroviral access program in sub-Sahara African countries. In 2000 he started a liver and kidney transplant program for people with HIV infection at the multivisceral transplant centre at Policlinico of Modena. Since 2002 he runs a Metabolic Clinic for HIV infection. This tertiary level referral center offers a multidisciplinary team consultant service consisting of infectious disease physicians, nutritionists, personal trainers for physical activities, psychologists, cardiologist, nephrologists, endocrinologists and plastic surgeons for diagnosis and treatment of Non-infectious Co-Morbidities. More than 4000 people are in charge of the Metabolic Clinic. He is a panel member of the European AIDS Clinical Society (EACS) guidelines on prevention and management of HIV-associated co-morbidities. He has published widely on clinical aspects of HIV treatment and care.

Dr. Keyur Patel

Keyur Patel, MD, PhD; Associate Professor of Medicine, Department of Medicine, Division of Gastroenterology, University of Toronto Health Network Dr. Patel received his Bachelor of Medicine degree from the University of Southampton, United Kingdom and completed his clinical fellowships in Internal Medicine and Gastroenterology/Hepatology in Perth, Australia. He completed a 3-year post-doctoral research fellowship in Clinical and Translational Research in viral hepatitis at Scripps Clinic and Research Foundation, San Diego, CA and Duke Clinical Research Institute, Durham NC. He was on faculty at Duke University 2004-2015 before moving to UHN Toronto in October 2015. His research interests include early phase clinical therapeutic trials for viral hepatitis and NASH fibrosis, and the development of non-invasive biomarkers of fibrosis progression.

Dr. Jennifer Price

Dr. Price is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at UCSF and Director of the UCSF Viral Hepatitis Center. Her research focuses on examining the contributions of novel and traditional factors associated with liver disease and fibrosis progression in large observational HIV cohorts, with or without viral hepatitis. She is the Director of the UCSF HCV Project Extension for Community Healthcare Outcome (ECHO) Program and the DeLIVER Care Van, a mobile medical unit aimed at improving the HCV care cascade in Northern California.

Dr. Patrick Ingiliz

Dr Patrick Ingiliz works as a clinical consultant in Infectiology at the Center for Infectiology in Berlin. He further holds a honorary academic lectureship at the Department for Hepatology and Gastroenterology at the University Medical Center at Charité, Berlin. He is actively involved in national and international research cooperations. His main clinical research topics are acute Hepatitis C, steatohepatitis in HIV, and liver fibrosis progression in viral diseases. He is further part of the scientific steering committee of CHECKPOINT Berlin (a senate funded sexual health center), and he is actively involved in numerous phase 2 and 3 trials in infectiology or liver diseases. During his training, he worked in an HIV/AIDS programme in subsahara Africa which focused on the implementation of antiretroviral therapy in Malawi, and is to date affiliated to the PROLIFICA program in West Africa. He furthermore completed a research fellowship at the Pitié-Salpêtrière liver unit in Paris.

Dr. Marina Klein

Dr. Marina Klein is Professor of Medicine, McGill University, Montreal, Canada in the Division of Infectious Diseases/Chronic Viral Illnesses. She graduated from McGill Medical School (1991) and received her training in Internal Medicine at the Royal Victoria Hospital in Montreal. She completed a research fellowship in Infectious Diseases at the University of Minnesota in 1998 and then returned to McGill University where she received a Master's degree in Epidemiology and Biostatistics (2003). Her clinical interests focus on treatment of patients with HIV and chronic viral hepatitis. She is a prominent researcher in clinical and epidemiologic aspects of HIV and Hepatitis C co-infection and leads a Canadian Institutes of Health Research (CIHR) funded prospective cohort study of over 1200 HIV-HCV co-infected patients to study the interaction of these chronic viral infections. She has also been a principal investigator in several clinical trials of HIV-HCV co-infection. Dr. Klein is also involved in a number of observational epidemiologic research collaborations (e.g. NA-ACCORD and CANOC) focused on understanding longterm clinical and treatment outcomes in HIV and in HIV-HCV co-infection where she has assumed a leadership role in scientific steering committees. She is currently serving as IAS Governing Council representative for the North American Region. In 2014 she assumed the role of National Co-Director of the CIHR-Canadian HIV Trials Network.

Dr. James Maurice

Dr James Maurice is a senior clinical fellow in hepatology and liver transplant at the Royal Free Hospital in London. He is currently completely a PhD on NAFLD in HIV mono-infection, with a focus on the risk factors for progressive disease and fibrosis and the role of innate immunity and the microbiome. He also has an interest in the non-invasive markers of portal hypertension.

Dr. Marc Deschenes

Dr. Marc Deschênes is Hepatologist at the Department of Medicine, Division of Gastroenterology & Hepatology & Transplantation of the McGill University Health Centre. He received his Bachelor of Medicine degree from the University of Montreal and completed his clinical fellowship in Gastroenterology/Hepatology at University of California San Francisco (UCSF) Medical Center. He is also an associate Professor at McGill University. His area of research is Liver Transplant.

First Name
Last Name
Email Address
Time Zone

By submitting this form, you are accepting the Privacy Statement.